BioSpace News Archive

Drug Development

Gilead, Arcus Anti-TIGIT Combo Gets Phase II Win in Upper GI Cancers

A combination of Gilead Sciences’ domvanalimab and Arcus Biosciences’ zimberelimab, along with chemo, has shown an “encouraging” overall response rate in a mid-stage study.

November 7, 2023
·
2 min read
·
Tyler Patchen
Job Trends

BioSpace Announces 2024 Best Places to Work in Biopharma

BioSpace has published its annual 2024 Best Places to Work list.

November 7, 2023
·
1 min read
·
Chantal Dresner
Career Advice

In Hiring, Some Companies Move Toward Focus on Skills Over Experience

Newer hiring models based on skills applicants have learned and their general potential for growth could avoid the drawbacks of relying on degrees and experience.

November 7, 2023
·
5 min read
·
Sruthi S. Balakrishnan
Vivoryon Therapeutics N.V. to Present at Upcoming November 2023 Investor Conference

Vivoryon Therapeutics N.V. announced that the Company’s management will present at the following conference.

November 7, 2023
·
3 min read
Mithra’s NEXTSTELLIS® granted additional patent in the United States

Mithra, a company dedicated to Women’s Health, announces that it has been granted an additional patent for NEXTSTELLIS® tablets) in the United States.

November 7, 2023
·
4 min read
Business

Innate Pharma Announces Conference Call for Third Quarter 2023 Business Update

Innate Pharma SA announced that the Company will hold a conference call on Tuesday, November 14, 2023, at 2 p.m. CET / 8 a.m. ET, to give an update on business progress during the third quarter of 2023.

November 7, 2023
·
4 min read
Nomination Committee Appointed for IRLAB’s Annual General Meeting 2024

IRLAB Therapeutics AB announced that the nomination committee ahead of the annual general meeting 2024 have been appointed.

November 7, 2023
·
3 min read
Business

Calliditas Interim Report January - September 2023

In August we were excited to see the full data set from our Phase 3 clinical trial, NefIgArd, published in The Lancet and we are looking forward to a potential full approval of TARPEYO for treatment of IgA Nephropathy, for which the PDUFA date is December 20, 2023.

November 7, 2023
·
6 min read
Antech launches first comprehensive veterinary diagnostics offering in the UK, including a new state-of-the-art reference laboratory

Antech, the full-service veterinary diagnostics business that is part of the Science & Diagnostics division of Mars Petcare, announced the opening of a new UK veterinary diagnostics laboratory in Warwick on 15 November.

November 7, 2023
·
3 min read
Business

Huma signs partnership with Merck KGaA, Darmstadt, Germany to support cancer care

Huma Therapeutics, a leading global digital health company, and Merck KGaA, Darmstadt, Germany, a leading science and technology company, announced a partnership to develop a digital solution that aims to help cancer patients better understand and manage their conditions and treatment.

November 7, 2023
·
3 min read